IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CANCARINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.710
EU - Europa 5.968
AS - Asia 2.082
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 13
AF - Africa 11
SA - Sud America 11
Totale 17.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.684
PL - Polonia 1.532
UA - Ucraina 1.444
CN - Cina 1.369
IT - Italia 1.220
DE - Germania 607
HK - Hong Kong 330
FI - Finlandia 317
GB - Regno Unito 243
FR - Francia 213
IE - Irlanda 212
SG - Singapore 201
IN - India 79
BE - Belgio 47
VN - Vietnam 45
RU - Federazione Russa 39
SE - Svezia 34
CA - Canada 23
CZ - Repubblica Ceca 20
IR - Iran 19
TR - Turchia 15
AU - Australia 13
EU - Europa 13
BR - Brasile 9
NL - Olanda 7
BD - Bangladesh 6
ES - Italia 6
RO - Romania 5
CH - Svizzera 4
JP - Giappone 4
BG - Bulgaria 3
EG - Egitto 3
ZA - Sudafrica 3
AT - Austria 2
AZ - Azerbaigian 2
HR - Croazia 2
ID - Indonesia 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MU - Mauritius 2
MX - Messico 2
PE - Perù 2
RS - Serbia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 17.809
Salva come PNG Salva come JPEG
Città #
Warsaw 1.531
Fairfield 1.359
Woodbridge 1.150
Jacksonville 1.048
Houston 777
Ashburn 701
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 502
Wilmington 463
Princeton 418
Nanjing 366
Hong Kong 328
Dublin 210
New York 187
Beijing 172
Helsinki 142
Nanchang 136
Milan 118
Singapore 115
Dearborn 113
Des Moines 103
Brescia 91
Hebei 82
Shenyang 77
Jiaxing 76
San Diego 73
Changsha 68
Rome 65
Tianjin 65
Jinan 52
Brussels 45
Dong Ket 44
Shanghai 43
Verona 43
Kunming 38
Boardman 34
Munich 32
Hangzhou 28
Lanzhou 27
London 24
Ningbo 24
San Mateo 23
Brno 20
Lancaster 20
Naples 20
Falls Church 19
Augusta 18
Monmouth Junction 18
Toronto 17
Zhengzhou 17
Leawood 16
Ardabil 15
Norwalk 14
San Francisco 14
Taizhou 14
Turin 14
Haikou 13
Los Angeles 13
Bergamo 12
Bologna 12
Changchun 12
Kocaeli 12
Florence 11
Palermo 11
Orange 10
Atlanta 8
Bari 8
Dallas 8
Guangzhou 8
Napoli 8
Avellino 7
Catania 7
Edinburgh 7
Hefei 7
Kilburn 7
Padova 7
Genoa 6
Melbourne 6
Mumbai 6
Phoenix 6
Prato 6
Redwood City 6
Taiyuan 6
Canberra 5
Chiswick 5
Foggia 5
Genova 5
New Rochelle 5
Perugia 5
Pisa 5
Pune 5
Berlin 4
Ferentino 4
Fuzhou 4
Grafing 4
Lachine 4
Nürnberg 4
Pesaro 4
Totale 13.329
Salva come PNG Salva come JPEG
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 790
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 350
Incremental peritoneal dialysis: a 10 year single-centre experience 263
Low-protein diets for chronic kidney disease patients: The Italian experience 223
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 218
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 188
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 184
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 175
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 174
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 172
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 172
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 167
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 167
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 157
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 156
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 154
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 150
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 148
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 147
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 141
Nutritional treatment of advanced CKD: twenty consensus statements 136
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 120
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 119
Differing dialysis treatment strategies and outcome. 119
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 118
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 115
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 113
Vascular access in older patients: an Italian survey. 113
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 111
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 110
Assessment of calcemic status in dialyzed uraemic patients. 109
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 109
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 109
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 109
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 108
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 107
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 107
Dialysis initiation: what's the rush? 104
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 104
The MEST score provides earlier risk prediction in lgA nephropathy 104
Diethylene Glycol Poisoning From Transcutaneous Absorption 103
Which vascular access for chronic hemodialysis in uremic elderly patients? 103
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 103
Clinical policies on the management of chronic kidney disease patients in Italy. 102
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 102
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 102
A six year comparison of patient and technique survivals in CAPD and HD 101
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 101
Experience with cyclosporine. 100
Porphyria and pseudo-porphyria in hemodialyzed patients. 99
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 99
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 99
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 99
A more tubulocentric view of diabetic kidney disease 99
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 98
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 96
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 96
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 95
Porphyria cutanea tarda in a haemodialysed patient. 95
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 95
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 94
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 94
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 93
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 93
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 92
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 91
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 91
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 90
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics 90
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 90
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 90
Myocardial ultrasound tissue characterization in patients with chronic renal failure 89
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 89
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region 89
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 88
Kidney transplantation in hiv-positive patients treated with a steroid-free immunosuppressive regimen. 88
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 88
Kidney transplantation in HIV-positive patients: a report of 14 cases 88
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 88
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 88
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 87
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 87
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 87
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 87
Transplantation outcome in patients PD and HD 86
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 86
Strategy for preventing peritoneal dialysis failure. 85
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 85
The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients 85
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). 85
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 84
Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma. 84
Fistula maturation: doesn't time matter at all? 83
PD or not PD? That is the question. 83
Outcome of peritoneal dialysis: comparative studies. 82
Plasma exchange in the treatment of acute renal failure of myeloma. 82
De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012 82
Chronic Ambulatory Peritoneal Dialysis 81
Renal transplantation and peritoneal dialysis 81
Management of hypertension in chronic renal failure. 81
Totale 12.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.406 0 215 208 585 323 590 460 572 360 580 187 326
2020/20213.348 92 378 159 408 149 380 141 377 485 262 358 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/2025117 50 67 0 0 0 0 0 0 0 0 0 0
Totale 18.091